Logo image of CNK

CINEMARK HOLDINGS INC (CNK) Stock Fundamental Analysis

NYSE:CNK - New York Stock Exchange, Inc. - US17243V1026 - Common Stock - Currency: USD

29.83  +0.08 (+0.27%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CNK. CNK was compared to 72 industry peers in the Entertainment industry. While CNK belongs to the best of the industry regarding profitability, there are concerns on its financial health. CNK has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CNK had positive earnings in the past year.
CNK had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CNK reported negative net income in multiple years.
CNK had a positive operating cash flow in 4 of the past 5 years.
CNK Yearly Net Income VS EBIT VS OCF VS FCFCNK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

CNK has a Return On Assets of 5.16%. This is amongst the best in the industry. CNK outperforms 83.33% of its industry peers.
CNK has a Return On Equity of 69.13%. This is amongst the best in the industry. CNK outperforms 95.83% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.83%, CNK belongs to the top of the industry, outperforming 80.56% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CNK is significantly below the industry average of 23.12%.
The 3 year average ROIC (5.91%) for CNK is below the current ROIC(7.83%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.16%
ROE 69.13%
ROIC 7.83%
ROA(3y)1.43%
ROA(5y)-2.94%
ROE(3y)-43.93%
ROE(5y)-67.71%
ROIC(3y)5.91%
ROIC(5y)N/A
CNK Yearly ROA, ROE, ROICCNK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

Looking at the Profit Margin, with a value of 8.02%, CNK belongs to the top of the industry, outperforming 84.72% of the companies in the same industry.
In the last couple of years the Profit Margin of CNK has grown nicely.
CNK has a better Operating Margin (10.66%) than 80.56% of its industry peers.
In the last couple of years the Operating Margin of CNK has remained more or less at the same level.
CNK's Gross Margin of 64.38% is fine compared to the rest of the industry. CNK outperforms 73.61% of its industry peers.
In the last couple of years the Gross Margin of CNK has remained more or less at the same level.
Industry RankSector Rank
OM 10.66%
PM (TTM) 8.02%
GM 64.38%
OM growth 3YN/A
OM growth 5Y-0.86%
PM growth 3YN/A
PM growth 5Y11.48%
GM growth 3Y-0.83%
GM growth 5Y0.4%
CNK Yearly Profit, Operating, Gross MarginsCNK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CNK is destroying value.
CNK has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CNK has more shares outstanding
Compared to 1 year ago, CNK has an improved debt to assets ratio.
CNK Yearly Shares OutstandingCNK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CNK Yearly Total Debt VS Total AssetsCNK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.22, we must say that CNK is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CNK (1.22) is comparable to the rest of the industry.
CNK has a debt to FCF ratio of 11.16. This is a negative value and a sign of low solvency as CNK would need 11.16 years to pay back of all of its debts.
CNK has a Debt to FCF ratio (11.16) which is in line with its industry peers.
CNK has a Debt/Equity ratio of 5.66. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CNK (5.66) is worse than 76.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.66
Debt/FCF 11.16
Altman-Z 1.22
ROIC/WACC0.92
WACC8.49%
CNK Yearly LT Debt VS Equity VS FCFCNK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 0.79 indicates that CNK may have some problems paying its short term obligations.
CNK's Current ratio of 0.79 is in line compared to the rest of the industry. CNK outperforms 44.44% of its industry peers.
CNK has a Quick Ratio of 0.79. This is a bad value and indicates that CNK is not financially healthy enough and could expect problems in meeting its short term obligations.
CNK has a Quick ratio (0.76) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.76
CNK Yearly Current Assets VS Current LiabilitesCNK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

CNK shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.83%.
The Earnings Per Share has been growing slightly by 4.49% on average over the past years.
Looking at the last year, CNK shows a decrease in Revenue. The Revenue has decreased by -0.80% in the last year.
CNK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.47% yearly.
EPS 1Y (TTM)4.83%
EPS 3YN/A
EPS 5Y4.49%
EPS Q2Q%-268.42%
Revenue 1Y (TTM)-0.8%
Revenue growth 3Y26.39%
Revenue growth 5Y-1.47%
Sales Q2Q%-6.65%

3.2 Future

Based on estimates for the next years, CNK will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.85% on average per year.
Based on estimates for the next years, CNK will show a small growth in Revenue. The Revenue will grow by 6.69% on average per year.
EPS Next Y-14.92%
EPS Next 2Y7.15%
EPS Next 3Y9.85%
EPS Next 5YN/A
Revenue Next Year9.13%
Revenue Next 2Y8.25%
Revenue Next 3Y6.69%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CNK Yearly Revenue VS EstimatesCNK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CNK Yearly EPS VS EstimatesCNK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.63 indicates a rather expensive valuation of CNK.
Based on the Price/Earnings ratio, CNK is valued cheaper than 84.72% of the companies in the same industry.
CNK's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.46.
With a Price/Forward Earnings ratio of 12.80, CNK is valued correctly.
88.89% of the companies in the same industry are more expensive than CNK, based on the Price/Forward Earnings ratio.
CNK's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.44.
Industry RankSector Rank
PE 19.63
Fwd PE 12.8
CNK Price Earnings VS Forward Price EarningsCNK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

CNK's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CNK is cheaper than 80.56% of the companies in the same industry.
84.72% of the companies in the same industry are more expensive than CNK, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.58
EV/EBITDA 9.98
CNK Per share dataCNK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The decent profitability rating of CNK may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.37
EPS Next 2Y7.15%
EPS Next 3Y9.85%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.07%, CNK has a reasonable but not impressive dividend return.
CNK's Dividend Yield is rather good when compared to the industry average which is at 6.27. CNK pays more dividend than 86.11% of the companies in the same industry.
With a Dividend Yield of 1.07, CNK pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 1.07%

5.2 History

CNK has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNK Yearly Dividends per shareCNK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y7.15%
EPS Next 3Y9.85%
CNK Yearly Income VS Free CF VS DividendCNK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CINEMARK HOLDINGS INC

NYSE:CNK (7/22/2025, 9:56:05 AM)

29.83

+0.08 (+0.27%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)08-01 2025-08-01/bmo
Inst Owners122.04%
Inst Owner Change0.96%
Ins Owners2.11%
Ins Owner Change-5.79%
Market Cap3.43B
Analysts75
Price Target34.51 (15.69%)
Short Float %21.37%
Short Ratio5.15
Dividend
Industry RankSector Rank
Dividend Yield 1.07%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date05-29 2025-05-29 (0.08)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-56.93%
Min EPS beat(2)-100.53%
Max EPS beat(2)-13.33%
EPS beat(4)2
Avg EPS beat(4)62.52%
Min EPS beat(4)-100.53%
Max EPS beat(4)254.24%
EPS beat(8)5
Avg EPS beat(8)64.97%
EPS beat(12)6
Avg EPS beat(12)-8.2%
EPS beat(16)7
Avg EPS beat(16)1.09%
Revenue beat(2)1
Avg Revenue beat(2)0.74%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)1.9%
Revenue beat(4)3
Avg Revenue beat(4)2.45%
Min Revenue beat(4)-0.41%
Max Revenue beat(4)5.09%
Revenue beat(8)7
Avg Revenue beat(8)2.96%
Revenue beat(12)10
Avg Revenue beat(12)2.73%
Revenue beat(16)13
Avg Revenue beat(16)6.14%
PT rev (1m)2.24%
PT rev (3m)4.42%
EPS NQ rev (1m)-2.44%
EPS NQ rev (3m)15.41%
EPS NY rev (1m)-1.16%
EPS NY rev (3m)-3.13%
Revenue NQ rev (1m)0.99%
Revenue NQ rev (3m)5.38%
Revenue NY rev (1m)-0.3%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 19.63
Fwd PE 12.8
P/S 1.14
P/FCF 15.58
P/OCF 9.28
P/B 9.82
P/tB N/A
EV/EBITDA 9.98
EPS(TTM)1.52
EY5.1%
EPS(NY)2.33
Fwd EY7.81%
FCF(TTM)1.91
FCFY6.42%
OCF(TTM)3.21
OCFY10.77%
SpS26.18
BVpS3.04
TBVpS-10.38
PEG (NY)N/A
PEG (5Y)4.37
Profitability
Industry RankSector Rank
ROA 5.16%
ROE 69.13%
ROCE 9.05%
ROIC 7.83%
ROICexc 9.75%
ROICexgc 21.27%
OM 10.66%
PM (TTM) 8.02%
GM 64.38%
FCFM 7.31%
ROA(3y)1.43%
ROA(5y)-2.94%
ROE(3y)-43.93%
ROE(5y)-67.71%
ROIC(3y)5.91%
ROIC(5y)N/A
ROICexc(3y)7.77%
ROICexc(5y)N/A
ROICexgc(3y)16.27%
ROICexgc(5y)N/A
ROCE(3y)6.83%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y17.77%
ROICexc growth 3YN/A
ROICexc growth 5Y8.59%
OM growth 3YN/A
OM growth 5Y-0.86%
PM growth 3YN/A
PM growth 5Y11.48%
GM growth 3Y-0.83%
GM growth 5Y0.4%
F-Score6
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 5.66
Debt/FCF 11.16
Debt/EBITDA 3.81
Cap/Depr 75.61%
Cap/Sales 4.96%
Interest Coverage 2.19
Cash Conversion 71.26%
Profit Quality 91.22%
Current Ratio 0.79
Quick Ratio 0.76
Altman-Z 1.22
F-Score6
WACC8.49%
ROIC/WACC0.92
Cap/Depr(3y)64.73%
Cap/Depr(5y)52.5%
Cap/Sales(3y)4.78%
Cap/Sales(5y)6.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.83%
EPS 3YN/A
EPS 5Y4.49%
EPS Q2Q%-268.42%
EPS Next Y-14.92%
EPS Next 2Y7.15%
EPS Next 3Y9.85%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.8%
Revenue growth 3Y26.39%
Revenue growth 5Y-1.47%
Sales Q2Q%-6.65%
Revenue Next Year9.13%
Revenue Next 2Y8.25%
Revenue Next 3Y6.69%
Revenue Next 5YN/A
EBIT growth 1Y-10.88%
EBIT growth 3YN/A
EBIT growth 5Y-2.31%
EBIT Next Year81.21%
EBIT Next 3Y29.04%
EBIT Next 5YN/A
FCF growth 1Y52.49%
FCF growth 3Y64.6%
FCF growth 5Y4.05%
OCF growth 1Y40.69%
OCF growth 3Y41.01%
OCF growth 5Y-3.68%